Wang Wei, Mani Arul M, Wu Zhao-Hui
Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
J Cancer Metastasis Treat. 2017;3:45-59. doi: 10.20517/2394-4722.2017.03. Epub 2017 Mar 27.
DNA damage is a vital challenge to cell homeostasis. Cellular responses to DNA damage (DDR) play essential roles in maintaining genomic stability and survival, whose failure could lead to detrimental consequences such as cancer development and aging. Nuclear factor-kappa B (NF-κB) is a family of transcription factors that plays critical roles in cellular stress response. Along with p53, NF-κB modulates transactivation of a large number of genes which participate in various cellular processes involved in DDR. Here the authors summarize the recent progress in understanding DNA damage response and NF-κB signaling pathways. This study particularly focuses on DNA damage-induced NF-κB signaling cascade and its physiological and pathological significance in B cell development and cancer therapeutic resistance. The authors also discuss promising strategies for selectively targeting this genotoxic NF-κB signaling aiming to antagonize acquired resistance and resensitize refractory cancer cells to cytotoxic treatments.
DNA损伤是对细胞稳态的重大挑战。细胞对DNA损伤的反应(DDR)在维持基因组稳定性和细胞存活中起着至关重要的作用,其功能失调可能导致诸如癌症发展和衰老等有害后果。核因子-κB(NF-κB)是一类转录因子,在细胞应激反应中发挥关键作用。与p53一起,NF-κB调节大量参与DDR相关各种细胞过程的基因的反式激活。在此,作者总结了在理解DNA损伤反应和NF-κB信号通路方面的最新进展。本研究特别关注DNA损伤诱导的NF-κB信号级联及其在B细胞发育和癌症治疗耐药性中的生理和病理意义。作者还讨论了选择性靶向这种基因毒性NF-κB信号的有前景的策略,旨在对抗获得性耐药并使难治性癌细胞对细胞毒性治疗重新敏感。